Literature DB >> 28526554

The roles of orexins in sleep/wake regulation.

Michihiro Mieda1.   

Abstract

Orexin A and orexin B are hypothalamic neuropeptides initially identified as endogenous ligands for two orphan G-protein coupled receptors (GPCRs). A deficiency of orexin signaling results in the sleep disorder narcolepsy-cataplexy in humans, dogs, and rodents, a sleep disorder characterized by excessive daytime sleepiness and cataplexy. Multiple approaches, including molecular genetic, electrophysiological, pharmacological, and neuroanatomical studies have suggested that orexins play critical roles in the maintenance of wakefulness by regulating the function of monoaminergic and cholinergic neurons that are implicated in the regulation of wakefulness. Here, I review recent advances in the understanding of how orexins regulate sleep/wakefulness and prevent narcolepsy.
Copyright © 2017 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Efferent pathway; GPCR; Monoamine; Narcolepsy; Orexin; Sleep/wakefulness

Mesh:

Substances:

Year:  2017        PMID: 28526554     DOI: 10.1016/j.neures.2017.03.015

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  19 in total

Review 1.  Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.

Authors:  Jessica R Barson
Journal:  Brain Res       Date:  2018-08-17       Impact factor: 3.252

Review 2.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

3.  Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex.

Authors:  Betina González; Subramaniam Jayanthi; Natalia Gomez; Oscar V Torres; Máximo H Sosa; Alejandra Bernardi; Francisco J Urbano; Edgar García-Rill; Jean-Lud Cadet; Verónica Bisagno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-12-13       Impact factor: 5.067

4.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

5.  Neurotransmitter networks in mouse prefrontal cortex are reconfigured by isoflurane anesthesia.

Authors:  Xiaoying Zhang; Aaron G Baer; Joshua M Price; Piet C Jones; Benjamin J Garcia; Jonathon Romero; Ashley M Cliff; Weidong Mi; James B Brown; Daniel A Jacobson; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurophysiol       Date:  2020-04-29       Impact factor: 2.714

Review 6.  Sleep-Aids Derived from Natural Products.

Authors:  Zhenzhen Hu; Seikwan Oh; Tae-Woo Ha; Jin-Tae Hong; Ki-Wan Oh
Journal:  Biomol Ther (Seoul)       Date:  2018-07-01       Impact factor: 4.634

7.  Lateral parabrachial neurons innervate orexin neurons projecting to brainstem arousal areas in the rat.

Authors:  Yosuke Arima; Shigefumi Yokota; Masashi Fujitani
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

8.  The effects of diurnal intermittent fasting on the wake-promoting neurotransmitter orexin-A.

Authors:  Aljohara S Almeneessier; Mohammed Alzoghaibi; Abdulrahman A BaHammam; Mahmoud G Ibrahim; Awad H Olaish; Samar Z Nashwan; Ahmed S BaHammam
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

9.  Wake-promoting effects of vagus nerve stimulation after traumatic brain injury: upregulation of orexin-A and orexin receptor type 1 expression in the prefrontal cortex.

Authors:  Xiao-Yang Dong; Zhen Feng
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

10.  Pharmacological Characteristics of Porcine Orexin 2 Receptor and Mutants.

Authors:  Min Liu; Tianqi Min; Haijie Zhang; Yuan Liu; Zhiqiang Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.